We Live Security (blog)Malware coded into synthetic genomesWe Live Security (blog)In the hypothetical case that a piece of modified DNA has been successfully synthesized, then the malicious code could form a part of a synthetic cell capable of replicat… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving AverageHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Pr… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving AverageModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Pre… Continue reading
STAT |
A new clue to hair loss: A misbehaving enzyme in follicle stem cells
STAT The study, published in Nature Cell Biology 1, finds that the metabolism in the stem cells embedded in hair follicles is different from surrounding cells. When they tinkered with that metabolic pathway in mice, they could either halt hair growth — or … |
STAT |
Could activating stem cells promote hair growth? UCLA scientists think they’ve found the metabolic root
STAT The study, published in Nature Cell Biology 1, finds that the metabolism in the stem cells embedded in hair follicles is different from surrounding cells. When they tinkered with that metabolic pathway in mice, they could either halt hair growth — or … |
|
Europe’s first stem cell therapy backed by NICE
PharmaTimes Eisai’s Holoclar, the first stem–cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition. The National Institute for Health and Care Excellence has now … |
|
First FDA-approved stem cell trial for shoulder injuries reaches full enrollment
News-Medical.net The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one’s own adipose stem cells are used … |